LAURUSLABS - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 4.7
| Stock Code | LAURUSLABS | Market Cap | 74,608 Cr. | Current Price | 1,382 ₹ | High / Low | 1,392 ₹ |
| Stock P/E | 101 | Book Value | 97.3 ₹ | Dividend Yield | 0.14 % | ROCE | 15.9 % |
| ROE | 15.1 % | Face Value | 2.00 ₹ | DMA 50 | 1,186 ₹ | DMA 200 | 1,008 ₹ |
| Chg in FII Hold | -0.70 % | Chg in DII Hold | 1.54 % | PAT Qtr | 192 Cr. | PAT Prev Qtr | 175 Cr. |
| RSI | 80.7 | MACD | 69.2 | Volume | 13,42,845 | Avg Vol 1Wk | 17,61,205 |
| Low price | 604 ₹ | High price | 1,392 ₹ | PEG Ratio | -113 | Debt to equity | 0.40 |
| 52w Index | 98.8 % | Qtr Profit Var | -23.9 % | EPS | 13.7 ₹ | Industry PE | 31.6 |
📈 Chart & Momentum Analysis
- Current price (₹1,382) is at the upper end of its 52-week range (₹1,392), showing strong bullish momentum.
- RSI at 80.7 indicates extreme overbought conditions, suggesting caution for new entries.
- MACD at 69.2 confirms strong upward momentum, but risk of short-term exhaustion.
- Price is trading well above DMA 50 (₹1,186) and DMA 200 (₹1,008), reinforcing a strong uptrend.
- Bollinger Bands show price hugging the upper band, signaling continuation but also volatility risk.
- Volume (13.4L) is below average weekly volume (17.6L), showing reduced participation near highs.
🎯 Entry & Exit Zones
- Optimal entry: ₹1,250–₹1,300 (near support and DMA 50).
- Exit/Profit zone: ₹1,380–₹1,420 (resistance near 52-week high).
- Stop-loss: ₹1,180 (DMA 50 support).
📊 Trend Status
- The stock is trending strongly upward but faces short-term consolidation risk due to overbought RSI.
---
Positive
✔ Strong uptrend above DMA 50 and DMA 200.
✔ MACD and RSI confirm momentum strength.
✔ Consistent higher highs and higher lows.
Limitation
⚠ RSI indicates overbought zone, risk of pullback.
⚠ Volume tapering near highs suggests weaker conviction.
⚠ Valuation stretched with P/E at 101.
Company Negative News
📉 Quarterly profit variation at -23.9% raises concerns.
📉 FII holdings reduced (-0.70%), showing cautious sentiment.
Company Positive News
📈 DII holdings increased (+1.54%), signaling domestic confidence.
📈 PAT growth from ₹175 Cr. to ₹192 Cr. quarter-on-quarter.
Industry
🏭 Pharma sector trading at Industry PE of 31.6, Laurus Labs significantly above peers.
🏭 Sector outlook remains positive with strong demand for APIs and formulations.
Conclusion
🔎 Laurus Labs is in a strong uptrend with momentum indicators favoring bulls. However, overbought RSI and stretched valuations suggest caution. Best strategy is to accumulate on dips near ₹1,250–₹1,300 with profit booking around ₹1,380–₹1,420.
Would you like me to expand this into a short-term intraday plan with tighter stop-loss levels, or a swing trade roadmap with holding period guidance?